Financial Performance - Revenue for Q2 2024 was $94.3 million, a decrease of $16.1 million (14.6%) compared to $110.4 million in Q2 2023 [4] - Net loss attributable to Sharecare increased to $42.0 million in Q2 2024 from $35.1 million in Q2 2023, an increase of $6.9 million [4] - Adjusted EBITDA was near break-even in Q2 2024, compared to $3.3 million in Q2 2023, a decrease of $3.3 million [4] - Net loss per share increased to $0.12 in Q2 2024 from $0.10 in Q2 2023, an increase of $0.02 [4] - Adjusted net loss per share was $0.04 in Q2 2024, compared to $0.03 in Q2 2023, an increase of $0.01 [4] Strategic Developments - The company successfully launched a new platform for Medicaid, reaching 750,000 members on July 1, 2024, as part of its Enterprise channel strategy [2] - The company is focused on accelerating growth and maximizing profitability by delivering proven solutions at higher operating margins while investing in innovation to drive consumerism in healthcare [5] - Sharecare entered into a definitive agreement to be acquired by an affiliate of Altaris, LLC, with Sharecare stockholders receiving $1.43 in cash per common share upon closing, expected by the end of 2024 [6] Non-GAAP Financial Measures - Adjusted EBITDA, adjusted net loss, and adjusted loss per share are used to evaluate ongoing operations and for internal planning and forecasting purposes [8] - Adjusted EBITDA excludes items such as depreciation, amortization, interest income/expense, share-based compensation, and non-operating, non-recurring costs [11] - Adjusted net loss excludes amortization of acquired intangibles, share-based compensation, and non-operating, non-recurring costs [20] - Adjusted loss per share is calculated as adjusted net loss divided by the weighted average common shares outstanding [21] Operational Costs and Adjustments - Non-operating, non-recurring costs for Q2 2024 included $1.8 million in legal matters and $0.2 million related to a financially distressed vendor [12][32] - Reorganizational and severance costs for Q2 2024 were $2.6 million, primarily related to globalizing the workforce and severance [17][34] - Acquisition-related costs for Q2 2024 were $4.7 million, primarily associated with the pending merger with Altaris [4][34]

Company Transactions - Sharecare Inc (NASDAQ: SHCR) is being sold to an affiliate of Altaris LLC for $1 43 per share in cash [1] - Morphic Holding Inc (NASDAQ: MORF) is being sold to Eli Lilly and Company for $57 00 per share in cash [2] Legal Investigation - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the transactions of Sharecare Inc and Morphic Holding Inc [1][2] - The law firm may seek increased consideration for shareholders additional disclosures or other relief on behalf of shareholders [3] Shareholder Rights - Shareholders of Sharecare Inc and Morphic Holding Inc are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options [4] - Halper Sadeh LLC represents investors worldwide in cases of securities fraud and corporate misconduct [4]

Law Firm Overview - Monteverde & Associates PC is a national class action securities firm with a successful track record in trial and appellate courts, including the US Supreme Court [1] - The firm has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report [3] - The firm is headquartered at the Empire State Building in New York City [3] Sharecare Merger Investigation - Monteverde & Associates PC is investigating Sharecare Inc (Nasdaq SHCR) relating to its proposed merger with an affiliate of Altaris LLC [3] - Under the terms of the agreement, Sharecare shareholders are expected to receive $1 43 in cash per share of common stock they own [3] Contact Information - The firm can be contacted through Juan Monteverde, Esq at the Empire State Building, 350 Fifth Ave Suite 4740, New York, NY 10118 [5] - Contact methods include email at jmonteverde@monteverdelaw com and telephone at (212) 971-1341 [5]

NEW YORK, July 15, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Sharecare, Inc. (Nasdaq: SHCR), relating to its proposed merger with an affiliate of Altaris, LLC. Under the terms of the agreement, Sharecare shareholders are expected to receive $1.43 in ca ...

NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Desktop Metal, Inc. (NYSE: DM)'s sale to Nano Dimension Ltd. for $5.50 per share. If you are a Desktop Metal shareholder, click here to learn more about your rights and options. Shareholders are encouraged to contact the firm free of charge to discuss their l ...

NEW YORK, June 22, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: MGO Global Inc. (NASDAQ: MGOL)'s merger with Heidmar, Inc. Under the terms of the proposed transaction, MGO shareholders will receive one registered common share of a newly incorporated Marshall Islands company for each share of MGO's common stock they own. M ...

Sharecare shareholders to receive $1.43 per share in cash ATLANTA, June 21, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, announced today that it has entered into a definitive agreement to be acquired by an affiliate of Altaris, LLC, an investment firm exclusively focused on the healthcare industry. Sharecare's comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health p ...

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR), the digital health company that helps people manage all their health in one place, today announced that on June 14, 2024, its Board of Directors (the "Board") adopted the Sharecare, Inc. 2024 Inducement Plan (the "Inducement Plan"), under which the Company may grant inducement equity awards outside of the Sharecare, Inc. 2021 Omnibus Incentive Plan, as amended. The Inducement Plan is used exclusively for the grant of equity awards to indiv ...

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR), the digital health company that helps people manage all their health in one place, today announced that on June 14, 2024, its Board of Directors (the "Board") adopted the Sharecare, Inc. 2024 Inducement Plan (the "Inducement Plan"), under which the Company may grant inducement equity awards outside of the Sharecare, Inc. 2021 Omnibus Incentive Plan, as amended. The Inducement Plan is used exclusively for the grant of equity awards to indiv ...

NEW YORK, June 18, 2024 /PRNewswire/ -- Details of the case: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Sharecare lacked adequate internal controls; and (2) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suf ...